Trial Profile
Open Label, Phase 3 Study of the Efficacy of Combination of Imiquimod and Cryosurgery in the Treatment of Primary Basal Cell Carcinomas of the Skin.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Sep 2011
Price :
$35
*
At a glance
- Drugs Imiquimod (Primary)
- Indications Basal cell cancer
- Focus Therapeutic Use
- 01 Sep 2011 Actual end date (Aug 2011) added as reported by ClinicalTrials.gov.
- 01 Sep 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 07 Oct 2010 New trial record